Medical Management of Early Pregnancy Failure: Efficacy

ABSTRACT

Early pregnancy failure is a common pregnancy complication. This article reviews the efficacy of medical management of early pregnancy failure. Nonsurgical treatments, including expectant and medical management, are reasonable alternatives to surgical management depending on the clinical situation and the patient's requests. Possible regimens in medical management of early pregnancy failure include misoprostol alone or mifepristone in conjunction with misoprostol. However, many studies of medical management may underestimate success rates due to inconsistent inclusion criteria, different dosing regimens, and varying definitions of failed treatment. Clinicians need to understand the range of efficacy of these regimens to provide appropriate counseling to patients.

KEYWORDS

Early pregnancy failure - miscarriage - missed abortion - misoprostol - mifepristone

REFERENCES

• 1 Hemminki E. Treatment of miscarriage: current practice and rationale.  Obstet Gynecol. 1998;  91 247-253
• 2 Warburton D, Fraser F C. Spontaneous abortion risks in man: data from reproductive histories collected in a medical genetics unit.  Am J Hum Genet. 1964;  16 1-25
• 3 Creinin M D, Schwartz J L, Guido R S, Pymar H C. Early pregnancy failure–current management concepts.  Obstet Gynecol Surv. 2001;  56 105-113
• 4 Creinin M D, Moyer R, Guido R. Misoprostol for medical evacuation of early pregnancy failure.  Obstet Gynecol. 1997;  89(5 Pt 1) 768-772
• 5 Gronlund A, Gronlund L, Clevin L et al.. Management of missed abortion: comparison of medical treatment with either mifepristone + misoprostol or misoprostol alone with surgical evacuation. A multi-center trial in Copenhagen county, Denmark.  Acta Obstet Gynecol Scand. 2002;  81 1060-1065
• 6 Bagratee J S, Khullar V, Regan L, Moodley J, Kagoro H. A randomized controlled trial comparing medical and expectant management of first trimester miscarriage.  Hum Reprod. 2004;  19 266-271
• 7 Zalányi S. Vaginal misoprostol alone is effective in the treatment of missed abortion.  Br J Obstet Gynaecol. 1998;  105 1026-1028
• 8 Zhang J, Gilles J M, Barnhart K et al.. A comparison of medical management with misoprostol and surgical management for early pregnancy failure.  N Engl J Med. 2005;  353 761-769
• 9 Creinin M D. Medical abortion regimens: historical context and overview.  Am J Obstet Gynecol. 2000;  183(2, Suppl) S3-S9
• 10 Nielsen S, Hahlin M. Expectant management of first-trimester spontaneous abortion.  Lancet. 1995;  345 84-86
• 11 Callen P W. Ultrasonography in Obstetrics and Gynecology. 4th ed. Philadelphia, PA; WB Saunders 2000
• 12 Harwood B, Meckstroth K R, Mishell D R, Jain J K. Serum beta-human chorionic gonadotropin levels and endometrial thickness after medical abortion.  Contraception. 2001;  63 255-256
• 13 Reynolds A, Ayres-de-Campos D, Costa M A, Montenegro N. How should success be defined when attempting medical resolution of first-trimester missed abortion?.  Eur J Obstet Gynecol Reprod Biol. 2005;  118 71-76
• 14 Creinin M D, Harwood B, Guido R S et al.. Endometrial thickness after misoprostol use for early pregnancy failure.  Int J Gynaecol Obstet. 2004;  86 22-26
• 15 Luise C, Jermy K, Collons W P, Bourne T H. Expectant management of incomplete, spontaneous first-trimester miscarriage: outcome according to initial ultrasound criteria and value of follow-up visits.  Ultrasound Obstet Gynecol. 2002;  19 580-582
• 16 Reeves M F, Lohr P A, Harwood B J, Creinin M D. Ultrasonographic endometrial thickness after medical and surgical management of early pregnancy failure.  Obstet Gynecol. 2008;  111 106-112
• 17 Cowett A A, Cohen L S, Lichtenberg E S, Stika C S. Ultrasound evaluation of the endometrium after medical termination of pregnancy.  Obstet Gynecol. 2004;  103(5 Pt 1) 871-875
• 18 Ngoc N TN, Blum J, Westheimer E, Quan T TV, Winikoff B. Medical treatment of missed abortion using misoprostol.  Int J Gynaecol Obstet. 2004;  87 138-142
• 19 Gilles J M, Creinin M D, Barnhart K et al.. A randomized trial of saline solution-moistened misoprostol versus dry misoprostol for first-trimester pregnancy failure.  Am J Obstet Gynecol. 2004;  190 389-394
• 20 Tang O S, Lau W NT, Ng E HY, Lee S WH, Ho P C. A prospective randomized study to compare the use of repeated doses of vaginal with sublingual misoprostol in the management of first trimester silent miscarriages.  Hum Reprod. 2003;  18 176-181
• 21 Tang O S, Ong C YT, Tse K Y et al.. A randomized trial to compare the use of sublingual misoprostol with or without an additional 1 week course for the management of first trimester silent miscarriage.  Hum Reprod. 2006;  21 189-192
• 22 Phupong V, Taneepanichskul S, Kriengsinyot R et al.. Comparative study between single dose 600 microg and repeated dose of oral misoprostol for treatment of incomplete abortion.  Contraception. 2004;  70 307-311
• 23 Nguyen T N, Blum J, Durocher J, Quan T TV, Winikoff B. A randomized controlled study comparing 600 versus 1,200 μg oral misoprostol for medical management of incomplete abortion.  Contraception. 2005;  72 438-442
• 24 Wood S L, Brain P H. Medical management of missed abortion: a randomized clinical trial.  Obstet Gynecol. 2002;  99 563-566
• 25 Blohm F, Friden B E, Milsom I, Platz-Christensen J J, Nielsen S. A randomised double blind trial comparing misoprostol or placebo in the management of early miscarriage.  BJOG. 2005;  112 1090-1095
• 26 Weeks A, Alia G, Blum J et al.. A randomized trial of misoprostol compared with manual vacuum aspiration for incomplete abortion.  Obstet Gynecol. 2005;  106 540-547
• 27 Bique C, Ustá M, Debora B et al.. Comparison of misoprostol and manual vacuum aspiration for the treatment of incomplete abortion.  Int J Gynaecol Obstet. 2007;  98 222-226
• 28 Shwekerela B, Kalumuna R, Kipingili R et al.. Misoprostol for treatment of incomplete abortion at the regional hospital level: results from Tanzania.  , [see comment] BJOG. 2007;  114 1363-1367
• 29 Demetroulis C, Saridogan E, Kunde D, Naftalin A A. A prospective randomized control trial comparing medical and surgical treatment for early pregnancy failure.  Hum Reprod. 2001;  16 365-369
• 30 Muffley P E, Stitely M L, Gherman R B. Early intrauterine pregnancy failure: a randomized trial of medical versus surgical treatment.  Am J Obstet Gynecol. 2002;  187 321-325
• 31 Graziosi G CM, Mol B WJ, Reuwer P JH, Drogtrop A, Bruinse H W. Misoprostol versus curettage in women with early pregnancy failure after initial expectant management: a randomized trial.  Hum Reprod. 2004;  19 1894-1899
• 32 Creinin M D, Huang X, Westhoff C et al.. Factors related to successful misoprostol treatment for early pregnancy failure.  Obstet Gynecol. 2006;  107 901-907
• 33 Asch R H, Weckstein L N, Balmaceda J P et al.. Non-surgical expulsion of non-viable early pregnancy: a new application of RU 486.  Hum Reprod. 1990;  5 481-483
• 34 Nielsen S, Hahlin M, Platz-Christensen J J. Unsuccessful treatment of missed abortion with a combination of an antiprogesterone and a prostaglandin E1 analogue.  Br J Obstet Gynaecol. 1997;  104 1094-1096
• 35 Coughlin L B, Roberts D, Haddad N G, Long A. Medical management of first trimester miscarriage (blighted ovum and missed abortion): is it effective?.  J Obstet Gynaecol. 2004;  24 69-71
• 36 Wagaarachchi P T, Ashok P W, Narvekar N, Smith N C, Templeton A. Medical management of early fetal demise using a combination of mifepristone and misoprostol.  Hum Reprod. 2001;  16 1849-1853
• 37 Schaff E A, Fielding S L, Eisinger S H, Stadalius L S, Fuller L. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days.  Contraception. 2000;  61 41-46
• 38 Creinin M D, Fox M C, Teal S et al.. A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortion.  Obstet Gynecol. 2004;  103(5 Pt 1) 851-859
• 39 Lelaidier C, Baton-Saint-Mleux C, Fernandez H, Bourget P, Frydman R. Mifepristone (RU 486) induces embryo expulsion in first trimester non-developing pregnancies: a prospective randomized trial.  Hum Reprod. 1993;  8 492-495
• 40 Nielsen S, Hahlin M, Platz-Christensen J. Randomised trial comparing expectant with medical management for first trimester miscarriages.  Br J Obstet Gynaecol. 1999;  106 804-807
• 41 Stockheim D, Machtinger R, Wiser A et al.. A randomized prospective study of misoprostol or mifepristone followed by misoprostol when needed for the treatment of women with early pregnancy failure.  Fertil Steril. 2006;  86 956-960
• 42 Niinimäki M, Jouppila P, Martikainen H, Talvensaari-Mattila A. A randomized study comparing efficacy and patient satisfaction in medical or surgical treatment of miscarriage.  Fertil Steril. 2006;  86 367-372
• 43 Schreiber C A, Creinin M D, Reeves M F, Harwood B J. Mifepristone and misoprostol for the treatment of early pregnancy failure: a pilot clinical trial.  Contraception. 2006;  74 458-462
• 44 Trinder J, Brocklehurst P, Porter R et al.. Management of miscarriage: expectant, medical, or surgical? Results of randomised controlled trial (miscarriage treatment [MIST] trial).  BMJ. 2006;  332 1235-1240
• 45 Shelley J M, Healy D, Grover S. A randomised trial of surgical, medical and expectant management of first trimester spontaneous miscarriage.  Aust N Z J Obstet Gynaecol. 2005;  45 122-127
• 46 Grønlund L, Grønlund A-L, Clevin L et al.. Spontaneous abortion: expectant management, medical treatment or surgical evacuation.  Acta Obstet Gynecol Scand. 2002;  81 781-782